BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Xu JX, Wu DH, Ying LW, Hu HG. Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization classification. World J Gastroenterol 2021; 27(47): 8123-8137 [PMID: 35068858 DOI: 10.3748/wjg.v27.i47.8123]
URL: https://www.wjgnet.com/1007-9327/full/v27/i47/8123.htm
Number Citing Articles
1
Efstathios Theodoros Pavlidis, Theodoros Efstathios Pavlidis. Molecular factors, diagnosis and management of gastrointestinal tract neuroendocrine tumors: An updateWorld Journal of Clinical Cases 2022; 10(27): 9573-9587 doi: 10.12998/wjcc.v10.i27.9573
2
Zenghong Wu, Guochen Shang, Kun Zhang, Weijun Wang, Mengke Fan, Rong Lin. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort studyInternational Journal of Surgery 2024; 110(4): 2178 doi: 10.1097/JS9.0000000000001080
3
Jim Smith, Edward Barnett, Euan J. Rodger, Aniruddha Chatterjee, Rathan M. Subramaniam. Neuroendocrine NeoplasmsPET Clinics 2023; 18(2): 169 doi: 10.1016/j.cpet.2022.11.003
4
Simron Singh, Diego Ferone, Jaume Capdevila, Jennifer Ang Chan, Wouter W. de Herder, Daniel Halperin, Josh Mailman, Lisa Hellström, Hanna Liedman, Agneta Svedberg, Fredrik Tiberg. Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NETTrials 2024; 25(1) doi: 10.1186/s13063-023-07834-8
5
Zenghong Wu, Weijun Wang, Kun Zhang, Mengke Fan, Rong Lin. The impact of surgery and survival prediction in patients with gastroenteropancreatic neuroendocrine tumors: a population-based cohort studyInternational Journal of Surgery 2023; 109(6): 1629 doi: 10.1097/JS9.0000000000000336